Recursion director files Form 4 sale of 25,000 shares
Recursion Pharmaceuticals director Robert Hershberg reported selling 25,000 shares at $5.00 on Oct. 6 under a 10b5-1 plan. The filing also shows he exercised 25,000 shares at $2.22.
Recursion Pharmaceuticals director Robert Hershberg reported selling 25,000 shares at $5.00 on Oct. 6 under a 10b5-1 plan. The filing also shows he exercised 25,000 shares at $2.22.